Long Term Surveillance of Islet Transplant Recipients Following Complete Graft Loss
Part of paid clinical trials in Miami, Florida.
- Sponsor
- Rodolfo Alejandro
- Study ID
- NCT02000687
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 75 Years
- Healthy Volunteers
- Not accepted
Study Details
This is a single-center, prospective, open label study in islet transplant recipients following islet graft loss.
Key Dates
- Start date
- Dec 31, 2008
- Status verified
- Mar 2026
- Primary completion
- Dec 31, 2027
- Completion
- Jul 31, 2028
Study Design
- Enrollment
- 60 participants (estimated)
Primary Outcome Measure
determine the rate of allosensitization in patients after failed islet transplantation [ Time Frame: 10 years ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Diabetes Research Institute | Miami | Florida | 33136 | Rodolfo Alejandro, MD (PRINCIPAL_INVESTIGATOR) David A Baidal, MD (SUB_INVESTIGATOR) |
Find similar trials in Miami, FL
By condition
By specialty
By research site
Related Studies
- Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft LossRecruiting · Rodolfo Alejandro · Miami, Florida
- Long Term Follow up of Recipients of Functional Islet AllograftsRecruiting · Rodolfo Alejandro · Miami, Florida
- FrexalimAB in Preservation of Endogenous insULIN Secretion Compared to Placebo in adUlts and Adolescents on Top of inSulin Therapy (FABULINUS)PHASE2 · Recruiting · Sanofi · San Francisco, California
- CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)PHASE1/PHASE2 · Recruiting · COUR Pharmaceutical Development Company, Inc. · Tucson, Arizona